日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Aprocitentan in Patients With Chronic Kidney Disease and Resistant Hypertension

阿普罗西坦治疗慢性肾病合并难治性高血压患者

Rossignol, Patrick; Clozel, Martine; Dreier, Roland F; Flack, John M; Flamion, Bruno; Mann, Johannes; Narkiewicz, Krzysztof; Sassi-Sayadi, Mouna; Wang, Ji-Guang; Weber, Michael A; Schlaich, Markus P

Effects of aprocitentan on prognostically relevant ambulatory blood pressure-derived variables in resistant hypertension

阿普罗西坦对难治性高血压患者预后相关动态血压指标的影响

Schlaich, Markus P; Weber, Michael A; Flack, John M; Danaietash, Parisa; Sassi-Sayadi, Mouna; Narkiewicz, Krzysztof; Wang, Ji-Guang

Regulatory Experiences with the Use of Multiple Imputation for Missing Data in a Phase 3 Confirmatory Trial

在3期确证性试验中使用多重插补法处理缺失数据的监管经验

Sassi-Sayadi, Mouna; Verweij, Pierre; Cornelisse, Peter

Long-Term Safety and Tolerability of Daridorexant in Patients with Insomnia Disorder

Daridorexant治疗失眠症患者的长期安全性和耐受性

Kunz, Dieter; Dauvilliers, Yves; Benes, Heike; García-Borreguero, Diego; Plazzi, Giuseppe; Seboek Kinter, Dalma; Coloma, Preciosa; Rausch, Magdalene; Sassi-Sayadi, Mouna; Thein, Stephen